Literature DB >> 19954388

Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.

Angela Yen Moore1.   

Abstract

Topical 5-fluorouracil (5-FU) has been used for the treatment of dermatological conditions for nearly half a century. Although the indications for 5-FU approved by the US Food and Drug Administration include actinic keratosis and superficial basal cell carcinoma, studies also have demonstrated therapeutic efficacy for 5-FU in the treatment of many other dermatological conditions, including squamous cell carcinoma in situ, warts, psoriasis of the nail, keratoacanthoma, and vitiligo. This review discusses clinical data which support the use of 5-FU for these disease states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954388     DOI: 10.3109/09546630902789326

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  12 in total

Review 1.  Novel investigational drugs for basal cell carcinoma.

Authors:  Po-Lin So; Jean Y Tang; Ervin H Epstein
Journal:  Expert Opin Investig Drugs       Date:  2010-09       Impact factor: 6.206

Review 2.  Advantages of combined photodynamic therapy in the treatment of oncological diseases.

Authors:  Mikhail Grin; Nikita Suvorov; Petr Ostroverkhov; Viktor Pogorilyy; Nikita Kirin; Alexander Popov; Anna Sazonova; Elena Filonenko
Journal:  Biophys Rev       Date:  2022-06-09

3.  Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug.

Authors:  Ana M T D P V Cabral; Ana C G Fernandes; Neuza A M Joaquim; Francisco Veiga; Sara P C Sofio; Isabel Paiva; Miguel A Esteso; M Melia Rodrigo; Artur J M Valente; Ana C F Ribeiro
Journal:  Toxics       Date:  2022-06-01

4.  Validation of actinic keratosis diagnosis and treatment codes among veterans living with HIV.

Authors:  Krittin J Supapannachart; Chase W Kwon; Sokol Tushe; Jodie L Guest; Suephy C Chen; Howa Yeung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-03-28       Impact factor: 2.732

5.  Clinical efficacy of short contact topical 5-Fluorouracil in the treatment of keratoacanthomas: a retrospective analysis.

Authors:  Bobbye J Thompson; Margaret Ravits; David N Silvers
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

Review 6.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

7.  Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosis.

Authors:  J Wood; M Pring; J W Eveson; N Price; C M Proby; A Hague
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

8.  The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil.

Authors:  Youssef W Naguib; Amit Kumar; Zhengrong Cui
Journal:  Acta Pharm Sin B       Date:  2014-02-01       Impact factor: 11.413

9.  Possible mechanisms by which topical 5-Fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study.

Authors:  Y Gauthier; T Anbar; S Lepreux; M Cario-André; L Benzekri
Journal:  ISRN Dermatol       Date:  2013-04-09

10.  A Comparative Study of Topical 5% 5-Fluorouracil with Needling versus 30% Trichloroacetic Acid with Needling in the Treatment of Plantar Warts.

Authors:  Sushma Jankal Basavarajappa; Radhakrishnan Subramaniyan; Rajeshwari Dabas; Sandeep V Lal; Manasa S Janney
Journal:  Indian Dermatol Online J       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.